UBS Group Issues Positive Forecast for Corteva (NYSE:CTVA) Stock Price

Corteva (NYSE:CTVA) had its price target boosted by UBS Group from $88.00 to $90.00 in a report published on Thursday,Benzinga reports. The firm currently has a neutral rating on the stock.

Several other research analysts have also recently weighed in on CTVA. Berenberg Bank upped their price objective on shares of Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research report on Thursday, March 26th. Weiss Ratings restated a “hold (c)” rating on shares of Corteva in a research report on Wednesday, April 22nd. Jefferies Financial Group upped their price objective on shares of Corteva from $95.00 to $97.00 in a research report on Thursday. CICC Research upped their price objective on shares of Corteva from $70.00 to $80.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 11th. Finally, Mizuho upped their price objective on shares of Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 15th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, Corteva currently has a consensus rating of “Moderate Buy” and a consensus price target of $86.95.

Corteva Price Performance

NYSE CTVA opened at $79.14 on Thursday. The company has a market cap of $53.13 billion, a PE ratio of 46.55, a price-to-earnings-growth ratio of 2.81 and a beta of 0.59. Corteva has a 52 week low of $60.53 and a 52 week high of $85.63. The company has a quick ratio of 0.96, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The firm’s 50-day simple moving average is $80.68 and its two-hundred day simple moving average is $72.61.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. During the same period in the prior year, the firm posted $1.13 earnings per share. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts predict that Corteva will post 3.62 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be issued a $0.18 dividend. The ex-dividend date is Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Insider Activity

In other news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the transaction, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.15% of the company’s stock.

Institutional Trading of Corteva

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its position in Corteva by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock valued at $5,398,392,000 after buying an additional 317,538 shares during the period. State Street Corp lifted its position in Corteva by 3.7% during the fourth quarter. State Street Corp now owns 36,570,876 shares of the company’s stock valued at $2,451,346,000 after buying an additional 1,290,071 shares during the period. Franklin Resources Inc. lifted its position in Corteva by 4.3% during the fourth quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock valued at $1,309,599,000 after buying an additional 805,873 shares during the period. Harris Associates L P lifted its position in Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after buying an additional 10,675,052 shares during the period. Finally, Northern Trust Corp lifted its position in Corteva by 5.0% during the fourth quarter. Northern Trust Corp now owns 11,731,834 shares of the company’s stock valued at $786,385,000 after buying an additional 562,550 shares during the period. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Key Stories Impacting Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Q1 results were strong — Corteva beat expectations, reaffirmed its 2026 outlook and said it remains on track for the planned 4Q-2026 separation, underpinning earnings visibility and growth prospects. Corteva Delivers Strong 1Q 2026 (Finanznachrichten)
• Positive Sentiment: Jefferies raised its price target to $97 (about ~21.6% upside vs. current levels), signaling bullish analyst conviction that could support further upside if investors follow. Jefferies raises PT to $97 (MarketScreener)
• Positive Sentiment: UBS lifted its price target to $90 (though it kept a “neutral” rating), which increases implied upside and may support buying interest among investors focused on valuation. UBS raises PT to $90 (Benzinga)
• Positive Sentiment: Citigroup raised its target to $85 while maintaining a “neutral” rating — another upward revision that suggests analysts are incrementally more constructive on Corteva’s outlook. Citigroup raises PT to $85 (TickerReport)
• Neutral Sentiment: Corteva management will speak at the BMO Global Farm to Market conference (May 14). Investor presentations and Q&A could provide incremental color but are routine events. Corteva to Participate in BMO Conference (PRNewswire)
• Neutral Sentiment: Full Q1 earnings call transcript and presentation are available for deeper detail on margins, guidance and separation timing — useful for active investors but not new headline news. Q1 Earnings Transcript (Yahoo) Earnings Call Transcript (Seeking Alpha)
• Negative Sentiment: BNP Paribas raised its target only to $77, which implies downside versus current levels and signals at least one analyst thinks upside is limited — a potential headwind for sentiment. BNP Paribas raises PT to $77 (MarketScreener)

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.